ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NRBO NeuroBo Pharmaceuticals Inc

3.37
-0.07 (-2.03%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
NeuroBo Pharmaceuticals Inc NRBO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -2.03% 3.37 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.44 3.26 3.49 3.37 3.44
more quote information »

Recent News

Date Time Source Heading
4/17/202408:05PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 1..
4/01/202408:01PRNUSNeuroBo Pharmaceuticals Completes Enrollment of Part 1 of..
3/28/202408:01PRNUSNeuroBo Pharmaceuticals Reports Year End 2023 Financial..
3/13/202408:01PRNUSNeuroBo Pharmaceuticals Receives Safety Review Committee..
3/04/202408:01PRNUSNeuroBo Pharmaceuticals Appoints Seasoned Life Science..
3/04/202407:30EDGAR2Form 8-K - Current report
2/29/202408:30EDGAR2Form 8-K - Current report
2/29/202408:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
2/14/202408:52EDGAR2Form 8-K - Current report
2/12/202408:01PRNUSNeuroBo Pharmaceuticals to Participate in the BIO CEO &..
2/01/202408:30EDGAR2Form 8-K - Current report
2/01/202408:01PRNUSNeuroBo Pharmaceuticals Announces FDA Clearance of IND for a..
1/18/202408:30EDGAR2Form 8-K - Current report
1/18/202408:01PRNUSNeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety..
1/09/202408:45EDGAR2Form 8-K - Current report
1/09/202408:30PRNUSNeuroBo Pharmaceuticals Regains Compliance with Nasdaq..
1/02/202408:01PRNUSNeuroBo to Participate in Industry and Investor Conferences..
12/28/202309:00EDGAR2Form 8-K - Current report
12/28/202308:45PRNUSNeuroBo Pharmaceuticals Submits IND Application to the FDA..
12/19/202309:03EDGAR2Form 8-K - Current report
12/19/202308:43PRNUSNeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock..
12/07/202309:20EDGAR2Form 8-K - Current report
12/01/202308:31PRNUSNeuroBo to Participate in Investor Conferences in December
11/13/202316:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:14EDGAR2Form 8-K - Current report
11/13/202316:05PRNUSNeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial..
11/06/202308:20EDGAR2Form 8-K - Current report
11/06/202308:05PRNUSNeuroBo Pharmaceuticals Strengthens Board of Directors with..
10/30/202308:06EDGAR2Form 8-K - Current report
10/17/202308:01PRNUSNeuroBo to Present at the H.C. Wainwright 7th Annual NASH..
9/22/202308:03EDGAR2Form 8-K - Current report
9/19/202316:15EDGAR2Form 8-K - Current report
9/15/202308:11EDGAR2Form 8-K - Current report
9/15/202308:01PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a..
8/24/202316:15EDGAR2Form 8-K - Current report
8/14/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202308:18EDGAR2Form 8-K - Current report
8/14/202308:01PRNUSNEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF..
8/09/202316:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:20EDGAR2Form 8-K - Current report
8/09/202316:05PRNUSNeuroBo Pharmaceuticals Reports Second Quarter 2023..
8/08/202316:15EDGAR2Form 8-K - Current report
8/03/202308:15EDGAR2Form 8-K - Current report
8/03/202308:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
8/02/202308:01PRNUSNeuroBo Pharmaceuticals Enters Into Term Sheet With MThera..
7/28/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/28/202306:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/28/202306:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
6/29/202308:36EDGAR2Form 8-K - Current report
6/27/202308:01PRNUSNeuroBo Pharmaceuticals' Novel GLP1R and GCGR Dual Agonist,..

Your Recent History

Delayed Upgrade Clock